146 related articles for article (PubMed ID: 18776977)
1. [A step foward in the treatment of GIST].
Fattoruso SI; Lopez M
Clin Ter; 2008; 159(4):223-4. PubMed ID: 18776977
[No Abstract] [Full Text] [Related]
2. Current management of GIST.
Blanke C
Clin Adv Hematol Oncol; 2004 May; 2(5):280, 283. PubMed ID: 17682286
[No Abstract] [Full Text] [Related]
3. KIT mutations and imatinib dose effects in patients with gastrointestinal stromal tumors.
De Giorgi U
J Clin Oncol; 2007 Mar; 25(9):1146-7; author reply 1147-8. PubMed ID: 17369583
[No Abstract] [Full Text] [Related]
4. Is there a role for neoadjuvant treatment with Gleevec for large rectal gastrointestinal stromal tumors?
Wasserberg N; Nunoo-Mensah JW; Beart RW; Ker TS
Int J Colorectal Dis; 2007 Aug; 22(8):981-2. PubMed ID: 16583196
[No Abstract] [Full Text] [Related]
5. FDA updates Gleevec label for GIST patients.
Schmidt C
J Natl Cancer Inst; 2012 Mar; 104(5):346. PubMed ID: 22349200
[No Abstract] [Full Text] [Related]
6. The GIST of a tumor's transformation.
Nelson B
Cancer Cytopathol; 2010 Jun; 118(3):114. PubMed ID: 20544705
[No Abstract] [Full Text] [Related]
7. Gastrointestinal Stromal Tumors (GIST) special issue. Preface.
Patel SR
Cancer Chemother Pharmacol; 2011 Jan; 67 Suppl 1():S1. PubMed ID: 21116629
[No Abstract] [Full Text] [Related]
8. Pathological response of gastrointestinal stromal tumour to imatinib treatment correlates with tumour KIT mutational status in individual tumour clones.
Loughrey MB; Beshay V; Dobrovic A; Zalcberg J; Waring PM
Histopathology; 2006 Jul; 49(1):99-100. PubMed ID: 16842259
[No Abstract] [Full Text] [Related]
9. Should adjuvant imatinib be used as primary treatment for gastrointestinal stromal tumors?
Hohenberger P
Nat Clin Pract Oncol; 2008 May; 5(5):240-1. PubMed ID: 18349856
[No Abstract] [Full Text] [Related]
10. [Targeted therapies in soft-tissue and visceral sarcomas].
Emile JF
Ann Pathol; 2009 Nov; 29 Spec No 1():S81-2. PubMed ID: 19887262
[No Abstract] [Full Text] [Related]
11. Patient with high-risk GIST not associated with c-KIT mutations: same benefit from adjuvant therapy?
Izquierdo ME; Bonastre MT
Anticancer Drugs; 2012 Jun; 23 Suppl():S7-9. PubMed ID: 22739668
[TBL] [Abstract][Full Text] [Related]
12. [Strategy for patients with GIST after failure of imatinib].
Abe S; Kubota T
Gan To Kagaku Ryoho; 2009 Apr; 36(4):540-3. PubMed ID: 19381023
[TBL] [Abstract][Full Text] [Related]
13. Pathological changes related to Imatinib treatment in a patient with a metastatic gastrointestinal stromal tumour.
Abdulkader I; Cameselle-Teijeiro J; Forteza J
Histopathology; 2005 Apr; 46(4):470-2. PubMed ID: 15810964
[No Abstract] [Full Text] [Related]
14. Optimizing the dose of imatinib for treatment of gastrointestinal stromal tumours: lessons from the phase 3 trials.
Patel S; Zalcberg JR
Eur J Cancer; 2008 Mar; 44(4):501-9. PubMed ID: 18234488
[TBL] [Abstract][Full Text] [Related]
15. [GIST: a clinical case as a model of surgical and pharmacological therapy of solid tumours].
D'Amato A; Pezzoli F; Caterino S; Cavallini M; Balducci G; Bocchetti T; Ziparo V
Chir Ital; 2005; 57(4):509-14. PubMed ID: 16060192
[TBL] [Abstract][Full Text] [Related]
16. [Gastrointestinal stromal tumor (GIST): pathology in continuous development. Diagnostic-therapeutic strategies].
Sianesi M
Ann Ital Chir; 2009; 80(4):257-60. PubMed ID: 19967882
[No Abstract] [Full Text] [Related]
17. Imatinib mesilate for the treatment of gastrointestinal stromal tumour.
Cassier PA; Dufresne A; Arifi S; El Sayadi H; Labidi I; Ray-Coquard I; Tabone S; Méeus P; Ranchère D; Sunyach MP; Decouvelaere AV; Alberti L; Blay JY
Expert Opin Pharmacother; 2008 May; 9(7):1211-22. PubMed ID: 18422477
[TBL] [Abstract][Full Text] [Related]
18. KIT/Val654 Ala receptor detected in one imatinib-resistant GIST patient.
Tamborini E; Gabanti E; Lagonigro MS; Negri T; Pilotti S; Pierotti MA; Pricl S
Cancer Res; 2005 Feb; 65(3):1115; author reply 1115. PubMed ID: 15705916
[No Abstract] [Full Text] [Related]
19. Should surgical resection be combined with imatinib therapy for locally advanced or metastatic gastrointestinal stromal tumors?
Yoon SS; Tanabe KK
Ann Surg Oncol; 2007 Jun; 14(6):1784-6. PubMed ID: 17356951
[No Abstract] [Full Text] [Related]
20. [A case of recurrent GIST successfully treated with low-dose imatinib mesilate].
Hanada N; Kawamura Y; Taneda T; Yoshida Y; Osako T; Inoue K
Gan To Kagaku Ryoho; 2006 Jun; 33(6):799-801. PubMed ID: 16770100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]